Skip to main content

Table 2 Comparison of cardiac function indices between the two groups

From: Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease

 

VHD group (n = 50)

Healthy control group (n = 55)

P

LVEDV (mL)

87.54 ± 14.87

75.41 ± 15.25

 < 0.001

LVESV (mL)

54.41 ± 9.92

37.15 ± 8.11

 < 0.001

  1. VHD Valvular Heart Disease, LVEDV Left Ventricular End-Diastolic Volume, LVESV Left Ventricular End-Systolic Volume